Role of endothelial-derived nitric oxide in hypertension and renal disease

被引:33
作者
Marin, Ethan
Sessa, William C.
机构
[1] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06536 USA
[2] Yale Univ, Sch Med, Boyer Ctr Mol Med, Program Vasc Cell & Transplantat, New Haven, CT 06536 USA
[3] Yale Univ, Sch Med, Dept Nephrol, New Haven, CT 06536 USA
关键词
caveolin; endothelial dysfunction; endothelium; nitric oxide; renal disease;
D O I
10.1097/MNH.0b013e328017f893
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Purpose of review To highlight recent advances in the field of endothelial-derived nitric oxide regulation of blood pressure and renal homeostasis. Recent findings Many laboratories have dissected a role for nitric oxide in regulating blood pressure and renal function. In models of hypertension, and chronic and acute renal disease, the loss of nitric oxide bioavailability may occur due to inactivation of endothelial nitric oxide synthase, synthesis of endogenous inhibitors or oxidative inactivation of nitric oxide. Summary Understanding the molecular mechanisms of nitric oxide synthesis may lead to novel diagnostics and treatments for cardiovascular disorders.
引用
收藏
页码:105 / 110
页数:6
相关论文
共 53 条
[1]
Nitric oxide deficiency in chronic renal disease [J].
Baylis, C .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 62 (Suppl 1) :123-130
[2]
Arginine, arginine analogs and nitric oxide production in chronic kidney disease [J].
Baylis, C .
NATURE CLINICAL PRACTICE NEPHROLOGY, 2006, 2 (04) :209-220
[3]
Adherence of uremic erythrocytes to vascular endothelium decreases endothelial nitric oxide synthase expression [J].
Bonomini, M ;
Pandolfi, A ;
Di Pietro, N ;
Sirolli, V ;
Giardinelli, A ;
Consoli, A ;
Amoroso, L ;
Gizzi, F ;
De Lutiis, MA ;
Felaco, M .
KIDNEY INTERNATIONAL, 2005, 67 (05) :1899-1906
[4]
In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation [J].
Bucci, M ;
Gratton, JP ;
Rudic, RD ;
Acevedo, L ;
Roviezzo, F ;
Cirino, G ;
Sessa, WC .
NATURE MEDICINE, 2000, 6 (12) :1362-1367
[5]
Disruption of the caveolin-1 gene impairs renal calcium reabsorption and leads to hypercalciuria and urolithiasis [J].
Cao, GW ;
Yang, GA ;
Timme, TL ;
Saika, T ;
Truong, LD ;
Satoh, T ;
Goltsov, A ;
Park, SH ;
Men, T ;
Kusaka, N ;
Tian, WH ;
Ren, CZ ;
Wang, HY ;
Kadmon, D ;
Cai, WW ;
Chinault, AC ;
Boone, TB ;
Bradley, A ;
Thompson, TC .
AMERICAN JOURNAL OF PATHOLOGY, 2003, 162 (04) :1241-1248
[6]
Renal protective effect of molsidomine and L-arginine in ischemia-reperfusion induced injury in rats [J].
Chander, V ;
Chopra, K .
JOURNAL OF SURGICAL RESEARCH, 2005, 128 (01) :132-139
[7]
Molsidomine, a nitric oxide donor and L-arginine protects against rhabdomyolysis-induced myoglobinuric acute renal failure [J].
Chander, V ;
Chopra, K .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2005, 1723 (1-3) :208-214
[8]
Role of caveolae and caveolins in health and disease [J].
Cohen, AW ;
Hnasko, R ;
Schubert, W ;
Lisanti, MP .
PHYSIOLOGICAL REVIEWS, 2004, 84 (04) :1341-1379
[9]
Role of renal NO production in the regulation of medullary blood flow [J].
Cowley, AW ;
Mori, T ;
Mattson, D ;
Zou, AP .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2003, 284 (06) :R1355-R1369
[10]
Endothelial nitric oxide synthase in vascular disease -: From marvel to menace [J].
Förstermann, U ;
Münzel, T .
CIRCULATION, 2006, 113 (13) :1708-1714